Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Jardiance and Its Alleged Connection to Fournier’s Gangrene

FDA Warning 

In August 2018, the FDA issued a warning regarding a possible link between SGLT2 inhibitors and Fournier’s gangrene. The warning came after the FDA’s analysis of events from 2013-2018 found several cases of Fournier’s gangrene in patients receiving SGLT2 inhibitors, including Jardiance. This warning served as the initial trigger for various legal actions against the manufacturers of these drugs, including Boehringer Ingelheim and Eli Lilly. [1]

Legal Actions and Lawsuits 

Several lawsuits were filed after the FDA warning, primarily focusing on the manufacturers’ alleged failure to properly warn patients and their physicians about the risk of Fournier’s gangrene. Plaintiffs argue that they were not informed about the potential risks and, therefore, could not make a well-informed decision about their treatment. [2]

Latest in the Litigation 

As of recent updates, the litigation process is ongoing. Both sides present robust arguments. The defendants maintain that they had adequately communicated all potential risks through their product labeling and deny any negligence in this matter. [3]

 On the other hand, plaintiffs insist that the potential risk of developing Fournier’s gangrene was not sufficiently explained, arguing that, had they been aware of these risks, they might have opted for alternative treatments. Courts have yet not reached a definitive conclusion. This case can potentially prompt further scrutiny regarding the responsibility of pharma companies in providing comprehensive safety data on their drugs and may set precedence for laws regulating drug safety information disclosure. [3]

If you or a loved one has suffered an injury from Jardiance, give us a call at the Michael Brady Lynch Firm at 888-585-5970 or brandon@mblynchfirm.com. 

Date: August 15, 2023

Author: Brandon Salter

Citations

[1] https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrences-serious-infection-genital-area-sglt2-inhibitors-diabetes

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450557/

[3] https://www.drugs.com/medical-answers/jardiance-perineum-3552698/#:~:text=Jardiance%20has%20a%20rare%20side,anus%20and%20vulva%20in%20women

Oxbryta Recall Prompts Lawsuits: What You Need to Know

Oxbryta Recall Prompts Lawsuits: What You Need to Know

Oxbryta was marketed as a revolutionary drug to help people suffering from sickle cell disease manage their most painful symptoms. Oxbryta was manufactured by Global Blood Therapeutics (which was later bought by Pfizer) and approved by the FDA in 2019 for children and adults 12 years old and older. It was approved for children four years old and up in 2021. Alarming results from post-launch trials showed that Oxbryta may increase the symptoms of sickle cell disease instead of decreasing them.

read more
Mass Tort Abuses in the Mormon Church: A Legal Perspective

Mass Tort Abuses in the Mormon Church: A Legal Perspective

In recent years, the Church of Jesus Christ of Latter-day Saints (LDS), commonly known as the Mormon Church, has faced increasing legal scrutiny due to allegations of widespread abuse and institutional cover-ups. have come forward with claims of sexual, emotional, and physical abuse, many of which involve church leaders or institutions. These lawsuits have begun to take the form of mass tort claims, as multiple plaintiffs allege a systemic pattern of negligence and concealment within the organization.

read more
Understanding Copyright Law for OnlyFans Creators

Understanding Copyright Law for OnlyFans Creators

OnlyFans has become a booming platform for influencers and content creators, allowing them to monetize their work directly through subscriptions. However, with the rise of digital content creation comes the inevitable challenge of copyright infringement. Many OnlyFans creators find their exclusive content stolen and redistributed on unaffiliated websites without their permission. If you’re an OnlyFans influencer facing this issue, you may have legal recourse to protect your rights.

read more
Update on The New Maryland Child Sexual Abuse Law

Update on The New Maryland Child Sexual Abuse Law

Maryland recently made a landmark change to its legal landscape by eliminating the civil statute of limitations for child sexual abuse cases under the **Child Victims Act of 2023**. This law, upheld by the Maryland Supreme Court in February 2025, allows survivors to file lawsuits regardless of how much time has passed since the abuse occurred.

read more
PIP Insurance Coverage Florida: How it Works

PIP Insurance Coverage Florida: How it Works

Florida is one of 12 “no-fault” insurance states, requiring drivers to carry Personal Injury Protection (PIP) insurance on vehicles operated in the state. PIP insurance allows injured drivers to receive compensation for damages and medical expenses by utilizing their insurance coverage.

read more
An Update on PFAS Cases: New Contamination Sites in US

An Update on PFAS Cases: New Contamination Sites in US

Per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” have been a growing concern due to their persistence in the environment and potential health risks. Recent developments have highlighted new contamination sites and legal actions aimed at addressing these issues across the United States.

read more
Nursing Home Abuse: An Overview

Nursing Home Abuse: An Overview

Nursing home abuse involves the mistreatment, neglect, or exploitation of residents in long-term care facilities. This includes skilled nursing homes, assisted living facilities, and other institutions responsible for the care of elderly or vulnerable adults. Under both federal and state laws, these facilities are required to provide residents with a safe, dignified, and compassionate environment.

read more
Oxbryta Recall: What You Need to Know

Oxbryta Recall: What You Need to Know

Oxbryta is a prescription medication developed to help people with sickle cell disease (SCD). It works by improving the oxygen-carrying ability of red blood cells and reducing the complications that come with SCD, like pain crises and organ damage. While it’s been seen as a breakthrough for managing this condition, a recent recall has raised serious concerns about its safety.

read more
×
What Our Clients Are Saying